Transforming Genomics for drug discovery and precision medicine
We are a rare mix of geneticists, bioinformaticians and technology experts who work together to decode the whole genome. We have developed Lucid to make cutting edge AI driven analysis easily available for researchers and clinicians.
Explore our LinkedIn
Our mission
We decode the full potential of the human genome, extracting 100% of DNA data with unprecedented precision and accuracy.
Our vision
We empower researchers, clinicians, and innovators to unlock discoveries, accelerate personalized treatments, and shape a healthier future. Every genome tells a story, and our technology ensures no detail is left unheard.
Meet the founders
Dr. Uirá Souto Melo
Co-founder & CEO
Ph.D in Genetics, expert in the "dark genome", an unexplored region of the genome that hides secrets about health and disease. With over 14 years of experience in the Genetics field, his expertise has been in the deployment of innovative sequencing technologies.
Uirá's ultimate goal is to turn genetic discoveries into practical applications that benefit society through the development of new diagnostic tools and individualized treatments in genomics.
Meet the Team
-
Dr. Uirá Souto Melo
Co-founder & CEO
Ph.D in Genetics, expert in the "dark-genome", an unexplored region of the genome that hides secrets about health and disease. With over 14 years of experience in the Genetics field, his expertise has been in the deployment of innovative sequencing technologies.
Uirá's ultimate goal is to turn genetic discoveries into practical applications that benefit society through the development of new diagnostic tools and individualized treatments in genomics.
-
Dr. M-Hossein Moeinzadeh
Co-founder & CTO
-
Achim Geppert
Co-founder & CCO
Advisors
-
Prof. Dr. Stefan Mundlos
Former director of the Institute for Medical and Human Genetics at the Charité
-
Prof. Dr. Martin Vingron
Director of the Max Planck Institute for Molecular Genetics
Our Partners
Our story
Interested in joining us?
Reach out to explore opportunities to collaborate with Lucid Genomics.